Spatial transcriptomics is an advanced technique that analyzes gene expression within tissue sections, such as those from the ...

The venture aims to advance MeiraGTx’s Parkinson’s gene therapy through Phase III trials with up to $430m in funding from ...

The startup will also use its generative AI technology to optimize manufacturing of the gene therapy, leveraging data that MeiraGTx has amassed over the course of nearly a decade developing its ...

artificial intelligence (AI) has been quietly improving the sector for years, from candidate prioritization in drug discovery to adverse event triage in clinical trials. Still, there are plenty of ...

Identifying therapeutic gene targets is essential for advancing personalized medicine and addressing the genetic basis of ...

AI researchers are celebrating a medical breakthrough: a new AI algorithm developed by a team of US researchers can detect ...

Traditional methods for identifying therapeutic gene targets, crucial for personalized medicine, are expensive and time-consuming. While artificial intelligence (AI), particularly deep learning ...

Artificial intelligence company Hologen AI has committed up to $430 million as part of a multifaceted agreement to help take MeiraGTx’s Parkinson’s disease gene therapy all the way to market.